Evidence map›Paper›PMID 37555885›Full record

ArticleInfection2023

Antiviral treatment of COVID-19: which role can clinical parameters play in therapy evaluation?

Yannis R Hübner, Nikolai Spuck, Moritz Berger, Stefan Schlabe, Gereon J Rieke, Sven Breitschwerdt, Kathrin van Bremen, Christian P Strassburg, Maria A Gonzalez-Carmona, Jan-Christian Wasmuth and 3 more

Abstract readLetterComment
In one paragraph

Article in Infection, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Yannis R HübnerDepartment of Internal Medicine I, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Nikolai SpuckFaculty of Medicine, Institute of Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany.
Moritz BergerFaculty of Medicine, Institute of Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany.
Stefan SchlabeDepartment of Internal Medicine I, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Gereon J RiekeDepartment of Internal Medicine I, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Sven BreitschwerdtDepartment of Internal Medicine I, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Kathrin van BremenDepartment of Internal Medicine I, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Christian P StrassburgDepartment of Internal Medicine I, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Maria A Gonzalez-CarmonaDepartment of Internal Medicine I, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Jan-Christian WasmuthDepartment of Internal Medicine I, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Jürgen K RockstrohDepartment of Internal Medicine I, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Christoph BoeseckeDepartment of Internal Medicine I, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Malte B MoninDepartment of Internal Medicine I, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany. malte_benedikt.monin@ukbonn.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Antiviral AgentsHumansSARS-CoV-2Antiviral Agents

Identifiers

PMID37555885
PMCPMC10665228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.